Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Scienture Holdings, Inc. Director's Dealing 2020

Apr 16, 2020

35013_dirs_2020-04-16_42b64073-672f-4f84-a686-e22890964baf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRXADE GROUP, INC. (MEDS)
CIK: 0001382574
Period of Report: 2020-04-14

Reporting Person: Patel Prashant (Director, President, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-14 Common stock A 50000 $6.12 Acquired 1255000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stock 400000 Indirect
Common stock 416667 Indirect

Footnotes

F1: Shares are fully earned as of April 14, 2020, The table above includes the full amount of such shares which are fully earned by the Reporting Person as of April 14, 2020, even though such shares have not been issued as of the date of this report.

F2: Issued to the Reporting Person as a compensation bonus for 2019. Exempt under Rule 16b-3(d).